Growth Metrics

Lexicon Pharmaceuticals (LXRX) EPS (Basic) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -13.31%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -100.00%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -79.34%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 61.11%
7 Evaxion A 64.16 Bn 64.14 Bn - -3,856.63%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -7.78%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,207.14%
10 Lexicon Pharmaceuticals 872.52 Mn 701.87 Mn 20.99 Mn 96.44%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 96.44%
Dec 31, 2025 55.56%
Sep 30, 2025 77.78%
Jun 30, 2025 105.88%
Mar 31, 2025 65.00%
Dec 31, 2024 55.00%
Sep 30, 2024 14.29%
Jun 30, 2024 22.73%
Mar 31, 2024 -17.65%
Dec 31, 2023 -17.65%
Sep 30, 2023 -61.54%
Jun 30, 2023 -37.50%
Mar 31, 2023 -6.25%
Dec 31, 2022 0.00%
Sep 30, 2022 18.75%
Jun 30, 2022 -23.08%
Mar 31, 2022 -6.67%
Dec 31, 2021 -466.67%
Sep 30, 2021 -120.78%
Jun 30, 2021 80.00%
Mar 31, 2021 76.19%
Dec 31, 2020 93.75%
Sep 30, 2020 -63.85%
Jun 30, 2020 -195.45%
Mar 31, 2020 -200.00%
Dec 31, 2019 -200.00%
Sep 30, 2019 919.23%
Jun 30, 2019 33.33%
Mar 31, 2019 47.50%
Dec 31, 2018 36.00%
Sep 30, 2018 7.14%
Jun 30, 2018 0.00%
Mar 31, 2018 -29.03%
Dec 31, 2017 19.35%
Sep 30, 2017 20.00%
Jun 30, 2017 10.81%
Mar 31, 2017 8.82%
Dec 31, 2016 -136.90%
Sep 30, 2016 -2.94%
Jun 30, 2016 -37.04%
Mar 31, 2016 -25.93%
Dec 31, 2015 2,900.00%
Sep 30, 2015 38.18%
Jun 30, 2015 22.86%
Mar 31, 2015 35.71%
Dec 31, 2014 0.00%
Sep 30, 2014 -816.67%
Jun 30, 2014 -483.33%
Mar 31, 2014 -740.00%
Dec 31, 2013 40.00%
Sep 30, 2013 0.00%
Jun 30, 2013 -20.00%
Mar 31, 2013 16.67%
Dec 31, 2012 50.00%
Sep 30, 2012 25.00%
Jun 30, 2012 37.50%
Mar 31, 2012 33.33%
Dec 31, 2011 -42.86%
Sep 30, 2011 0.00%
Jun 30, 2011 -14.29%